Waldman WJ - Search Results

1

Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytes.

Adams PW, Lee HS, Waldman WJ, Sedmak DD, Orosz CG. Adams PW, et al. Among authors: waldman wj. Transplantation. 1994 Aug 27;58(4):476-83. Transplantation. 1994. PMID: 7915443

2

Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related.

Magro CM, Klinger DM, Adams PW, Orosz CG, Pope-Harman AL, Waldman WJ, Knight D, Ross P Jr. Magro CM, et al. Among authors: waldman wj. Am J Transplant. 2003 Oct;3(10):1264-72. doi: 10.1046/j.1600-6143.2003.00229.x. Am J Transplant. 2003. PMID: 14510700 Free article.

3

T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells.

Waldman WJ, Adams PW, Orosz CG, Sedmak DD. Waldman WJ, et al. Transplantation. 1992 Nov;54(5):887-96. doi: 10.1097/00007890-199211000-00024. Transplantation. 1992. PMID: 1332226

4

Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells.

Adams PW, Lee HS, Waldman WJ, Sedmak DD, Morgan CJ, Ward JS, Orosz CG. Adams PW, et al. Among authors: waldman wj. J Immunol. 1992 Jun 15;148(12):3753-60. J Immunol. 1992. PMID: 1351087

5

Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression.

Sedmak DD, Roberts WH, Stephens RE, Buesching WJ, Morgan LA, Davis DH, Waldman WJ. Sedmak DD, et al. Among authors: waldman wj. Transplantation. 1990 Feb;49(2):458-62. doi: 10.1097/00007890-199002000-00043. Transplantation. 1990. PMID: 2154873

6

In vitro induction of endothelial adhesion molecule and MHC antigen expression by cytomegalovirus-activated CD4+ T cells.

Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. Waldman WJ, et al. Transplant Proc. 1995 Feb;27(1):1269-71. Transplant Proc. 1995. PMID: 7533377 No abstract available.

7

In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells.

Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. Waldman WJ, et al. Transplantation. 1993 Dec;56(6):1504-12. doi: 10.1097/00007890-199312000-00043. Transplantation. 1993. PMID: 7904091

8

Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells.

Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, Waldman WJ. Sedmak DD, et al. Among authors: waldman wj. Am J Pathol. 1994 Apr;144(4):683-92. Am J Pathol. 1994. PMID: 8160770 Free PMC article.

9

Endothelial HLA class II induction mediated by allogeneic T cells activated by cytomegalovirus-infected cultured endothelial cells.

Waldman WJ, Knight DA, VanBuskirk A, Adams PW, Orosz CG, Sedmak DD. Waldman WJ, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1439-40. Transplant Proc. 1993. PMID: 8382874 No abstract available.

10

CMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro.

Waldman WJ, Adams PW, Knight DA, Sedmak DD. Waldman WJ, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):1545-6. doi: 10.1016/s0041-1345(96)00670-7. Transplant Proc. 1997. PMID: 9123420 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters